SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies soars on winning WHO GDP certification for quality services across entire supply chain

09 Mar 2022 Evaluate

Venus Remedies is currently trading at Rs. 286.05, up by 14.10 points or 5.18% from its previous closing of Rs. 271.95 on the BSE.

The scrip opened at Rs. 274.25 and has touched a high and low of Rs. 291.25 and Rs. 274.25 respectively. So far 6316 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 638.50 on 09-Aug-2021 and a 52 week low of Rs. 225.00 on 09-Mar-2021.

Last one week high and low of the scrip stood at Rs. 293.35 and Rs. 265.00 respectively. The current market cap of the company is Rs. 382.36 crore.

The promoters holding in the company stood at 40.81%, while Institutions and Non-Institutions held 0.28% and 58.91% respectively.

Venus Remedies has received the coveted WHO Good Distribution Practices (GDP) certification from Societe Generale de surveillance (SGS), the world’s reading resting, inspection and certification company, in a resounding endorsement of its quality services throughout the entire supply chain cycle.

Committed to quality in every aspect of its services right from the manufacturing stage to delivery of products to end-customers, the company has consistently maintained impeccable standards in its distribution operations and processes through proven quality management systems.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers. It has world-class manufacturing facilities in Panchkula and Baddi (in India) and Werne (in Germany) and research and development center in Venus Medicine Research Centre (in India).

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×